Robert M. Bilder, Ph.D., ABPP-CN

Dr. Bilder is currently Chief of Medical Psychology - Neuropsychology, and Senior Research Scientist, Ahmanson-Lovelace Brain Mapping Center, Jane & Terry Semel Institute for Neuroscience & Human Behavior, and Lynda & Stewart Resnick Neuropsychiatric Hospital; and Professor In Residence of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine, and Psychology, at UCLA.  Dr. Bilder received a bachelors degree from Columbia College of Columbia University in Biology and Psychology (1978), and a Ph.D. in Psychology from City College, City University of New York, where he specialized in human neuropsychology (1984).   He did his Internship in the Division of Neuropsychology, New York State Neurological Institute, Columbia-Presbyterian Medical Center (1982).   Before joining UCLA in 2002, Dr. Bilder held a series of faculty appointments at Columbia University College of Physicians & Surgeons and the Albert Einstein College of Medicine.  He served as Chief of Neuropsychology at Zucker Hillside Hospital of North Shore - Long Island Jewish Medical Center from 1988 to 2002, and was Associate Director for Human Research at the Center for Advanced Brain Imaging at the Nathan Kline Institute for Psychiatric Research from 1996 to 2002.  Dr. Bilder has been awarded diplomate status by the American Board of Clinical Neuropsychology.

Dr. Bilder is a Clinical Neuropsychologist who has been actively engaged for over 20 years in research on the neuroanatomic and neuropsychological bases of major mental illnesses.  He has received many awards for his research contributions, served on diverse federal and international advisory boards, provided editorial service to many scholarly journals, and received multiple grants from the NIH, private foundations, and industry.  His work has been presented in more than 100 peer-reviewed publications and 300 scientific presentations.  Dr. Bilder's research focuses on drug treatment and genetic effects on brain structure and function, particularly using neurocognitive and magnetic resonance imaging (MRI) methods.  He recently began developing an interdisciplinary Center for Cognitive Phenomics (www.phenomics.ucla.edu) under the aegis of the NIH Roadmap Initiative (P20-RR020750) to identify and study the neural system phenotypes that offer the most promising targets for gene and drug discovery.

Home Page | Publications | Biosketch

To contact us:

Phone: 310-825-9474
Fax: 310-206-8525
Email: rbilder@mednet.ucla.edu